This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,700.05 firm fixed-price delivery order covers the supply of ADBRY 150 MG/ML SYRINGEML, with a completion date of December 11, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
The contract award does not have a set-aside designation, indicating open competition. As a leading pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying medical products to various federal government agencies, including the DLA, which oversees the procurement and distribution of supplies for the U.S. military and other defense-related programs.
Generated 3/11/25, 9:55 AM